Dailypharm Live Search Close

This situation of mixing Lyrica with other doses is absurd

By Kang, Shin-Kook | translator Choi HeeYoung

21.03.18 06:20:27

°¡³ª´Ù¶ó 0
Multinational companies must fulfill their responsibility for quality control and follow-up measures



When it was confirmed that Pfizer Korea's Lyrica had mixed drugs with different doses, The Korean Pharmaceutical Association urged a countermeasure to prevent recurrence. The KPA(Chairman Dae-eop Kim) made a statement on the 17th, saying, "The case where different doses of pharmaceuticals are mixed & packaging in the bottle is a serious problem that should not exist in the GMP process." "The basics of quality control have not been observed," he pointed out.

The KPA said, "The government has achieved success in joining the Pharmaceutical Inspection Co-operation Scheme (PIC/S) to enhance the international reliability of the quality of domestic drugs, but paradoxically, the management of overseas manufac

Kang, Shin-Kook(ksk@dailypharm.com)
If you want to see the full article, please JOIN US (click)